Mitralign, Inc. To Update On Mitral and Tricuspid Repair Systems at EuroPCR 2015

TEWKSBURY, Mass.--(BUSINESS WIRE)--Mitralign is reinforcing its position as the only company to provide a direct percutaneous annuloplasty system designed to treat both functional mitral regurgitation (FMR) and tricuspid regurgitation (TR). At EuroPCR the week of May 17 in Paris, the company will present updates on its mitral and tricuspid valve repair systems including a presentation of six month data on its Mitral system.

Help employers find you! Check out all the jobs and post your resume.